Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): Updated results from a phase II trial.

被引：0
|
作者：
Shen, Bo
Wu, Yuan
Shi, Lin
Pan, Banzhou
Yang, Kaihua
Wang, Qiong
Zhao, Weiqing
Han, Zhengxiang
Wang, Lifeng
Feng, Jifeng
机构：
[1] Jiangsu Canc Hosp, Nanjing, Peoples R China
[2] Jiangnan Univ, Hosp, Wuxi, Jiangsu, Peoples R China
[3] Jiangyin Peoples Hosp, Jiangyin, Peoples R China
[4] First Peoples Hosp Changzhou, Changzhou, Jiangsu, Peoples R China
[5] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
[6] Nanjing Univ, Drum Tower Hosp, Med Sch, Comprehens Canc Ctr, Nanjing, Peoples R China
[7] Nanjing Univ, Clin Canc Inst, Nanjing, Peoples R China
[8] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20610
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Final results and subgroup analysis of ORIENTAL: A phase IIIB study of durvalumab plus platinum-etoposide in firstline treatment of Chinese patients with extensive-stage small-cell lung cancer (ES-SCLC)
    Cheng, Y.
    Wang, J.
    Yao, W.
    Yu, Y.
    Zang, A.
    Cao, L.
    Lv, D.
    Li, S.
    Meng, Z.
    Zhang, J.
    Guo, Q.
    Huang, D.
    Liu, A.
    Liu, J.
    Mao, W.
    Tang, K.
    Zhang, Y.
    Chen, E.
    Wang, Z.
    Zheng, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1673 - S1673
  • [42] Carfilzomib (CFZ), carboplatin and etoposide for previously untreated extensive-stage small cell lung cancer (ES-SCLC): Phase 1b results from a phase 1b/2 study.
    Badin, Firas Benyamine
    Chiang, Anne C.
    Fisher, William B.
    Orlov, Sergey
    Harper, Harry D.
    Eskander, Elhamy
    Harb, Wael A.
    Kio, Ebenezer
    Gopalan, Priya Kadambi
    Haggstrom, Daniel Ernest
    Burdaeva, Olga
    Zahlten-Kumeli, Anita
    Aggarwal, Sanjay
    Obreja, Mihaela
    Gorbunova, Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
    Takahashi, T.
    Mori, K.
    Mizuno, R.
    Mamesaya, N.
    Kobayashi, H.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Naito, T.
    Murakami, H.
    Kenmotsu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1165 - S1165
  • [44] LUMINANCE: A Phase IIIb Study of Durvalumab plus Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
    Reinmuth, N.
    DeMarinis, F.
    Leighl, N.
    Sadow, S.
    Davey, K.
    Ozguroglu, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
  • [45] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)
    Socinski, M
    Weissman, C
    Hart, L
    Beck, J
    Choksi, J
    Hanson, J
    Prager, D
    Bloss, L
    Ze, Y
    Obasaju, C
    LUNG CANCER, 2005, 49 : S328 - S329
  • [46] Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as fi rst-line therapy for extensive-stage small-cell - cell lung cancer (ES-SCLC): a phase II trial
    Chen, Dawei
    Zou, Bing
    Li, Butuo
    Gao, Aiqin
    Huang, Wei
    Shao, Qian
    Meng, Xiangjiao
    Zhang, Pinliang
    Tang, Xiaoyong
    Hu, Xudong
    Zhang, Yan
    Guo, Jun
    Zhao, Changhong
    Yuan, Jiajia
    Li, Qian
    Zhu, Changbin
    Yu, Jinming
    Wang, Linlin
    ECLINICALMEDICINE, 2024, 75
  • [47] A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC).
    Socinski, MA
    Weissman, CH
    Hart, LL
    Beck, JT
    Choksi, JK
    Hanson, JP
    Prager, D
    Bloss, LP
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 661S - 661S
  • [48] Toripalimab and anlotinib as a maintenance treatment for extensive-stage small-cell lung cancer: a case report
    Wu, Guixian
    Huang, Jing
    Lin, Ling
    Yan, Shuangquan
    Pan, Weijia
    Chen, Qian
    Wu, Xiaomai
    Lv, Dongqing
    IMMUNOTHERAPY, 2022, 14 (13) : 1007 - 1013
  • [49] Phase I/II Trial Of 177Lu-DOTA0-Tyr3-Octreotate (Lutathera) And Nivolumab for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Kim, C.
    Subramaniam, D.
    Liu, S.
    Giaccone, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S791 - S791
  • [50] Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Pietanza, Maria Catherine
    Krug, Lee M.
    Varghese, Anna M.
    Fleisher, Martin
    Teitcher, Jerrold B.
    Holodny, Andrei
    Sima, Camelia S.
    Litvak, Anna Maria
    Ng, Kenneth K.
    Patel, Payal R.
    Ibrahim, Fawzia
    Haughney-Siller, Anne
    Dulko, Dorothy
    Monger, Grace
    Albano, Melanie
    Moran, Clare M.
    Kris, Mark G.
    Rudin, Charles M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345